Shares of Atomera surged 14.9% to $3.47 in pre-market trading on October 22, defying a weak chip sector backdrop after the company announced a joint development agreement with IQE, the world's largest independent compound semiconductor wafer maker. The deal marks a turning point for a company that has spent years licensing a technology almost nobody has yet paid to mass-produce.
• A Credible Manufacturing Partner Changes the Equation. Atomera signed the agreement with IQE to develop cost-effective RF GaN solutions using Atomera's proprietary thin-film technology on silicon wafers, combined with IQE's epitaxy expertise.
IQE is headquartered in Cardiff with manufacturing sites in the U.K., U.S., and Taiwan , and is considered the largest independent epiwafer foundry globally. For Atomera, whose previous GaN work was largely conducted in university and government labs, IQE will actually manufacture the wafers for foundry and integrated device manufacturer customers — giving Atomera a commercial pathway it hasn't had before.
• The Target Market Is Huge, But Atomera's Slice Is Uncertain. The RF GaN market reached roughly $2.4 billion in 2026 and is growing near 20% annually. Today, most RF GaN chips use expensive silicon carbide substrates. GaN-on-silicon — the cheaper alternative Atomera is pursuing — is projected to expand at a 21.35% compound annual growth rate through 2031 , driven by 5G and consumer electronics demand. But Atomera's role would be collecting licensing fees and per-wafer royalties, not selling chips, so the company generates revenue primarily through licensing fees, development agreements, and engineering services.
• The Financial Reality Is Stark. Atomera's trailing-twelve-month revenue stands at just $230,000, and full-year 2025 revenue was $65,000.
The company posted a net loss of $6.3 million in Q2 2026 alone.
It held $38.4 million in cash as of June 30 , giving it roughly seven to eight quarters of runway at its current burn rate — enough to develop but not enough to wait indefinitely.
• Breakthrough Lab Results Need a Factory Floor. Atomera claims its technology delivers over 1,000x lower harmonic distortion on GaN-on-silicon substrates than control devices — a metric RF designers care deeply about. The agreement envisions a multi-cycle engineering process before potentially expanding into power electronics. Translation: revenue from this partnership is quarters, not weeks, away. At a $118 million market cap, investors are pricing in faith that a lab discovery becomes a licensing stream — but the IQE deal is the most concrete step yet toward making that happen.